Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment of ALS
SPG302 is being developed as a once-a-day pill with the potential to regenerate synapses to reverse declines in cognitive and...
EHR
ModMed Earns Top Spot on Six Grids for its EHR and RCM Software in G2’s Spring 2024 Report
The healthcare technology leader was recognized in 28 G2 Spring 2024 Reports and earned 9 badges in G2's spring report,...
NextGen Healthcare to Support Ohio Nonprofit’s Delivery of Whole-Person Care for Children and Adults with Disabilities
I Am Boundless Inc. Focuses on Integration and Patient Outcomes Across 50+ Counties in the StateREMOTE-FIRST COMPANY/WORTHINGTON, Ohio--(BUSINESS WIRE)--#NextGenHealthcare--Driven by...
CytoDyn to Host Webcast to Provide Company Update
VANCOUVER, Washington, May 28, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing...
Novartis atrasentan Phase III data show clinically meaningful proteinuria reduction further advancing company’s IgA nephropathy (IgAN) portfolio
In the ALIGN study, atrasentan, in addition to supportive care with a renin-angiotensin system (RAS) inhibitor, demonstrated a statistically significant 36.1% proteinuria (protein in urine)...
Novartis presents latest Phase III Fabhalta® (iptacopan) data in C3 glomerulopathy (C3G) showing clinically meaningful and statistically significant 35.1% proteinuria reduction vs. placebo
Secondary endpoint data for estimated glomerular filtration rate (eGFR) showed numerical improvement over 6 months vs. placebo1; additional 6-month open-label...
TruBridge Announces Participation in the Stifel Cross Sector Insight Conference
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the Stifel Cross Sector...
GRM Information Management to Attend the 2024 MUSE Inspire Conference
Visit GRM Information Management in Booth #125 at the 2024 MUSE Inspire Conference in Denver, CO May 28-31JERSEY CITY, N.J.--(BUSINESS...
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
CTX-471, a novel anti-CD137 agonist antibody, demonstrated anti-tumor activity in the Company’s Phase 1 Dose Escalation and Dose Expansion, first-in-human...
TruBridge Awarded Peer Review Designation by Healthcare Financial Management Association
HFMA acknowledges TruBridge Medical Coding Services and the company’s value to the healthcare ecosystem.MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a...
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
Additional clinical and real-world data from the industry’s largest and broadest amyloidosis pipeline will advance understanding of underlying mechanisms of...
eClinicalWorks and Sunoh.ai Help Women’s Health Clinic Save Over Two Hours on Clinical Documentation Daily
Rocky Mountain Women’s Clinic reaps the benefits of the AI-powered medical scribe, with enhanced clinical efficiency and improved work-life balanceWESTBOROUGH,...
REPEAT – Media Conference – Update: Fightback to Save Durham Hospital Ratcheting Up
TORONTO and GREY BRUCE, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- It is a small community, but it has raised...
MD Revolution CIO Dr. Jean Balgrosky Recognized by Becker’s Hospital Review 2024 “Women in Health IT to know” List
SAN DIEGO--(BUSINESS WIRE)--MD Revolution’s longtime Chief Information Officer, Jean Balgrosky, PhD, was named by Becker’s Hospital Review as one of...
Is this 911 call truly an emergency? ESO Research looks at dispatch protocols and patient outcomes to understand 911 prioritization measures
Study represents a significant step in enhancing emergency response amid rising call volume and resource constraints.AUSTIN, Texas--(BUSINESS WIRE)--ESO, a leading...
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering
AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering...
HYAS Infosec Named “Best Overall Healthcare Cybersecurity Company” in 8th Annual MedTech Breakthrough Awards Program
HYAS Insight Advanced Threat Intelligence and HYAS Protect Protective DNS Proactively Thwart Attacks on the Healthcare Sector Before Damage Can...
MEDITECH’s Traverse Exchange Canada Connects to Oracle e-Hub and Provincial Resources
19 MEDITECH hospitals and 279 long-term care sites are now connected through the groundbreaking interoperability networkCANTON, Mass.--(BUSINESS WIRE)--MEDITECH’s Traverse Exchange...
IHI Appoints Susan Ehrlich, CEO of Zuckerberg San Francisco General, to its Board of Directors
BOSTON--(BUSINESS WIRE)--#IHIForum--The Institute for Healthcare Improvement (IHI) announced today that Susan Ehrlich, MD, MPP, has joined its Board of Directors....
The Foundation for the National Institutes of Health Announces the Launch of a Public-Private Partnership to Accelerate ALS Diagnosis and Treatment
The Accelerating Medicines Partnership® in Amyotrophic Lateral Sclerosis (AMP® ALS) will create the largest open data platform for ALS research...